A detailed history of Jane Street Group, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 76,920 shares of GKOS stock, worth $9.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
76,920
Previous 47,303 62.61%
Holding current value
$9.41 Million
Previous $4.46 Million 104.1%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $2.65 Million - $3.51 Million
29,617 Added 62.61%
76,920 $9.1 Million
Q1 2024

May 15, 2024

SELL
$76.4 - $96.33 $5.01 Million - $6.32 Million
-65,574 Reduced 58.09%
47,303 $4.46 Million
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $6.19 Million - $8.85 Million
104,025 Added 1175.16%
112,877 $8.97 Million
Q3 2023

Nov 14, 2023

SELL
$69.23 - $79.09 $1.72 Million - $1.96 Million
-24,842 Reduced 73.73%
8,852 $666,000
Q2 2023

Aug 14, 2023

BUY
$45.44 - $71.21 $843,230 - $1.32 Million
18,557 Added 122.59%
33,694 $2.4 Million
Q1 2023

May 15, 2023

SELL
$43.88 - $52.48 $879,179 - $1.05 Million
-20,036 Reduced 56.96%
15,137 $758,000
Q4 2022

Feb 14, 2023

SELL
$40.82 - $57.75 $1.73 Million - $2.45 Million
-42,379 Reduced 54.65%
35,173 $1.54 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $879,608 - $1.1 Million
18,779 Added 31.95%
77,552 $4.13 Million
Q3 2022

Nov 14, 2022

BUY
$46.84 - $58.49 $879,608 - $1.1 Million
18,779 Added 31.95%
77,552 $4.13 Million
Q2 2022

Aug 16, 2022

BUY
$34.86 - $63.77 $1.73 Million - $3.16 Million
49,532 Added 536.0%
58,773 $2.67 Million
Q1 2022

May 17, 2022

SELL
$44.33 - $57.82 $89,546 - $116,796
-2,020 Reduced 17.94%
9,241 $534,000
Q4 2021

Feb 15, 2022

SELL
$40.27 - $56.99 $966,963 - $1.37 Million
-24,012 Reduced 68.07%
11,261 $501,000
Q3 2021

Nov 16, 2021

BUY
$47.43 - $84.23 $1.14 Million - $2.02 Million
24,017 Added 213.37%
35,273 $1.7 Million
Q2 2021

Aug 16, 2021

SELL
$73.06 - $97.7 $31,196 - $41,717
-427 Reduced 3.65%
11,256 $955,000
Q1 2021

May 18, 2021

SELL
$70.43 - $97.42 $310,244 - $429,135
-4,405 Reduced 27.38%
11,683 $981,000
Q3 2020

Nov 17, 2020

BUY
$37.23 - $50.97 $258,227 - $353,527
6,936 Added 75.79%
16,088 $796,000
Q2 2020

Aug 17, 2020

BUY
$28.78 - $46.83 $263,394 - $428,588
9,152 New
9,152 $351,000
Q3 2019

Nov 14, 2019

SELL
$58.58 - $83.91 $245,215 - $351,247
-4,186 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$63.59 - $78.71 $549,608 - $680,290
-8,643 Reduced 67.37%
4,186 $316,000
Q1 2019

May 16, 2019

BUY
$50.75 - $80.54 $334,188 - $530,355
6,585 Added 105.46%
12,829 $1.01 Million
Q4 2018

Feb 15, 2019

BUY
$52.18 - $67.93 $325,811 - $424,154
6,244 New
6,244 $351,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $5.82B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.